Global Pharmatech, Inc. (GBLP)
Global Pharmatech, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Hong Kong, MA, HK. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $33.3M. On trailing twelve-month figures it carries a trailing P/E of 800.90, a net margin of 8.3%. Its beta of 0.28 implies it has historically moved less than the broad market.
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA. The company was founded on June 26, 2001 and is headquartered in Hong Kong.
Global Pharmatech, Inc. is most often compared with the following Healthcare names: